Drug hypersensitivity syndrome (DHS) is a severe idiosyncratic reaction associated with drug therapy. Cutaneous eruptions are the most common idiosyncratic reaction to drugs, but DHS is not just a drug-related eruption. We defined DHS by the clinical triad of fever, rash, and internal organ involvement.1 The pathogenesis of this disease is not well defined; however, intriguing clinical and laboratory observations and associations provide insight into the mechanistic puzzle of this iatrogenic disease. The article in this issue by Descamps et al2 raises further questions as to this syndrome's association with viral infection. Understanding the pathomechanism of DHS is important for the prevention and improved management of these potentially life-threatening reactions.
The potential interplay of factors reported with drug hypersensitivity syndrome. Drug hypersensitivity reactions occur more commonly in women than in men in most studies.
The potential role of reactive drug metabolites. Chemically reactive drug products usually constitute only a minor proportion of a drug's metabolites but are probably responsible for many serious adverse effects, including hypersensitivity reactions.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 127
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.